NEW YORK, May 6 (GenomeWeb News) - Orchid BioSciences reported increased revenues and widening losses for the first quarter of 2004 today.
Revenues for the quarter totaled $13.5 million, up from $12.7 million during the first quarter of 2003.
Registering provides access to this and other free content.
Already have an account?Login Now.
Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.
In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.
Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.
In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.